260 related articles for article (PubMed ID: 34739879)
1. Multiparametric magnetic resonance imaging features of giant intracranial tuberculomas.
Peer S; Tiwari S; Swaminathan AD; Jabeen S; Saini J; Prasad C; Kulanthaivelu K; Murumkar V; Vengalil S; Netravathi M; Nalini A; Raju S; Swaroop NS; Srinivas D
Clin Neurol Neurosurg; 2021 Nov; 210():107006. PubMed ID: 34739879
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of intracranial tuberculomas using diffusion-weighted imaging (DWI), magnetic resonance spectroscopy (MRS) and susceptibility weighted imaging (SWI).
Parry AH; Wani AH; Shaheen FA; Wani AA; Feroz I; Ilyas M
Br J Radiol; 2018 Nov; 91(1091):20180342. PubMed ID: 29987985
[TBL] [Abstract][Full Text] [Related]
3. Brain CT and MRI findings in 100 consecutive patients with intracranial tuberculoma.
Wasay M; Kheleani BA; Moolani MK; Zaheer J; Pui M; Hasan S; Muzaffar S; Bakshi R; Sarawari AR
J Neuroimaging; 2003 Jul; 13(3):240-7. PubMed ID: 12889171
[TBL] [Abstract][Full Text] [Related]
4. Role of Multiparametric Magnetic Resonance Imaging of the Brain in Differentiating Neurocysticercosis From Tuberculoma.
Joy L; Sakalecha AK
Cureus; 2023 May; 15(5):e39003. PubMed ID: 37323306
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of intracranial tuberculomas and high grade gliomas using proton MR spectroscopy and diffusion MR imaging.
Peng J; Ouyang Y; Fang WD; Luo TY; Li YM; Lv FJ; Zhang ZW; Li XY
Eur J Radiol; 2012 Dec; 81(12):4057-63. PubMed ID: 22749802
[TBL] [Abstract][Full Text] [Related]
6. Intracranial giant tuberculoma: A 7-year institutional experience and literature review.
Swamy SBG; Jaikumar V; Nagaraj NM; Khandelwal S
Clin Neurol Neurosurg; 2023 Feb; 225():107593. PubMed ID: 36701938
[TBL] [Abstract][Full Text] [Related]
7. Magnetization transfer MR imaging correlation with histopathology in intracranial tuberculomas.
Gupta RK; Husain N; Kathuria MK; Datta S; Rathore RK; Husain M
Clin Radiol; 2001 Aug; 56(8):656-63. PubMed ID: 11467867
[TBL] [Abstract][Full Text] [Related]
8. Intracranial tuberculoma: comparison of MR with pathologic findings.
Kim TK; Chang KH; Kim CJ; Goo JM; Kook MC; Han MH
AJNR Am J Neuroradiol; 1995 Oct; 16(9):1903-8. PubMed ID: 8693993
[TBL] [Abstract][Full Text] [Related]
9. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
[TBL] [Abstract][Full Text] [Related]
10. Intravascular papillary endothelial hyperplasia: magnetic resonance imaging of finger lesions.
Sung J; Kim JY; Yoo C
Skeletal Radiol; 2016 Feb; 45(2):235-42. PubMed ID: 26603891
[TBL] [Abstract][Full Text] [Related]
11. T2/FLAIR-mismatch sign for noninvasive detection of IDH-mutant 1p/19q non-codeleted gliomas: validity and pathophysiology.
Foltyn M; Nieto Taborda KN; Neuberger U; Brugnara G; Reinhardt A; Stichel D; Heiland S; Herold-Mende C; Unterberg A; Debus J; von Deimling A; Wick W; Bendszus M; Kickingereder P
Neurooncol Adv; 2020; 2(1):vdaa004. PubMed ID: 32642675
[TBL] [Abstract][Full Text] [Related]
12. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM
J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590
[TBL] [Abstract][Full Text] [Related]
13. The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
Fouke SJ; Benzinger T; Gibson D; Ryken TC; Kalkanis SN; Olson JJ
J Neurooncol; 2015 Dec; 125(3):457-79. PubMed ID: 26530262
[TBL] [Abstract][Full Text] [Related]
14. MR imaging features of isolated cortical vein thrombosis: diagnosis and follow-up.
Boukobza M; Crassard I; Bousser MG; Chabriat H
AJNR Am J Neuroradiol; 2009 Feb; 30(2):344-8. PubMed ID: 19095790
[TBL] [Abstract][Full Text] [Related]
15. Dynamic susceptibility contrast-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between H3-mutant and H3-wild-type high-grade midline glioma.
Kurokawa R; Kurokawa M; Baba A; Ota Y; Kim J; Capizzano A; Srinivasan A; Moritani T
Eur Radiol; 2022 Jun; 32(6):3672-3682. PubMed ID: 35022811
[TBL] [Abstract][Full Text] [Related]
16. Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas.
Yang X; Lin Y; Xing Z; She D; Su Y; Cao D
Acta Radiol; 2021 Dec; 62(12):1657-1665. PubMed ID: 33222488
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of magnetization transfer MR imaging and in-vivo proton MR spectroscopy in brain tuberculomas.
Gupta RK; Husain M; Vatsal DK; Kumar R; Chawla S; Husain N
Magn Reson Imaging; 2002 Jun; 20(5):375-81. PubMed ID: 12206861
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric Framework Magnetic Resonance Imaging Assessment of Subtypes of Intracranial Germ Cell Tumors Using Susceptibility Weighted Imaging, Diffusion-Weighted Imaging, and Dynamic Susceptibility-Contrast Perfusion-Weighted Imaging Combined With Conventional Magnetic Resonance Imaging.
Li Y; Wang P; Zhang J; Li J; Chen L; Qiu X
J Magn Reson Imaging; 2022 Oct; 56(4):1232-1242. PubMed ID: 35278008
[TBL] [Abstract][Full Text] [Related]
20. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF
Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
